Presight Capital

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
2
Rounds led
0
Rounds' value
$65.5M
total disclosed, rounds participated
Stages
—

Portfolio · 1

Chemomab Therapeutics
Innovative Treatments for Patients with Fibro-Inflammatory-Related Diseases
2 rounds $65.5M committed Latest: 2021-03

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Presight Capital's primary sector focus for investments?
Presight Capital has shown a focus on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits being in this area.
Can you name a notable exit for Presight Capital?
In March 2021, Presight Capital had an exit with Chemomab Therapeutics through a Reverse Merger Event, which led to Chemomab Therapeutics being listed on NASDAQ.
What type of funding rounds has Presight Capital participated in?
Presight Capital has participated in C Round and PIPE funding stages.
When was Presight Capital founded?
Presight Capital was created in March 2021, according to startupim data.
What is the investment range for Presight Capital?
Presight Capital's investment range is between $20M and $45.5M.
Which company is a key part of Presight Capital's portfolio?
Chemomab Therapeutics, a company focused on innovative treatments for fibro-inflammatory-related diseases, is a key part of Presight Capital's portfolio.